| Year |
Citation |
Score |
| 2023 |
Arvin AM. Creating the "Dew Drop on a Rose Petal": the Molecular Pathogenesis of Varicella-Zoster Virus Skin Lesions. Microbiology and Molecular Biology Reviews : Mmbr. e0011622. PMID 37354037 DOI: 10.1128/mmbr.00116-22 |
0.383 |
|
| 2022 |
Sen N, Arvin AM. Modulation of Host Cell Signaling Pathways by Varicella-Zoster Virus. Current Topics in Microbiology and Immunology. PMID 35624345 DOI: 10.1007/82_2021_251 |
0.304 |
|
| 2021 |
Telenti A, Arvin A, Corey L, Corti D, Diamond MS, García-Sastre A, Garry RF, Holmes EC, Pang P, Virgin HW. After the pandemic: perspectives on the future trajectory of COVID-19. Nature. PMID 34237771 DOI: 10.1038/s41586-021-03792-w |
0.312 |
|
| 2020 |
Vanni EAH, Foley JW, Davison AJ, Sommer M, Liu D, Sung P, Moffat J, Zerboni L, Arvin AM. The latency-associated transcript locus of herpes simplex virus 1 is a virulence determinant in human skin. Plos Pathogens. 16: e1009166. PMID 33370402 DOI: 10.1371/journal.ppat.1009166 |
0.358 |
|
| 2020 |
Oliver SL, Zhou M, Arvin AM. Varicella-zoster virus: molecular controls of cell fusion-dependent pathogenesis. Biochemical Society Transactions. PMID 33259590 DOI: 10.1042/BST20190511 |
0.366 |
|
| 2020 |
Zhou M, Kamarshi V, Arvin AM, Oliver SL. Calcineurin phosphatase activity regulates Varicella-Zoster Virus induced cell-cell fusion. Plos Pathogens. 16: e1009022. PMID 33216797 DOI: 10.1371/journal.ppat.1009022 |
0.375 |
|
| 2020 |
Sen N, Mukherjee G, Arvin AM. The Use of Single Cell Mass Cytometry to Define the Molecular Mechanisms of Varicella-Zoster Virus Lymphotropism. Frontiers in Microbiology. 11: 1224. PMID 32676054 DOI: 10.3389/fmicb.2020.01224 |
0.405 |
|
| 2019 |
Arvin AM. Will Measles Virus or Humanity Win the International "Fitness" Challenge? Annual Review of Virology. 6: iii-vii. PMID 31567068 DOI: 10.1146/annurev-vi-06-072619-100011 |
0.331 |
|
| 2019 |
Mullane KM, Morrison VA, Camacho LH, Arvin A, McNeil SA, Durrand J, Campbell B, Su SC, Chan ISF, Parrino J, Kaplan SS, Popmihajlov Z, Annunziato PW. Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial. The Lancet. Infectious Diseases. PMID 31399378 DOI: 10.1016/S1473-3099(19)30310-X |
0.356 |
|
| 2019 |
Mahalingam R, Gershon A, Gershon M, Cohen JI, Arvin A, Zerboni L, Zhu H, Gray W, Messaoudi I, Traina-Dorge V. Current In Vivo Models of Varicella-Zoster Virus Neurotropism. Viruses. 11. PMID 31159224 DOI: 10.3390/V11060502 |
0.477 |
|
| 2018 |
Zerboni L, Sung P, Sommer M, Arvin A. The C-terminus of varicella-zoster virus glycoprotein M contains trafficking motifs that mediate skin virulence in the SCID-human model of VZV pathogenesis. Virology. 523: 110-120. PMID 30119012 DOI: 10.1016/J.Virol.2018.08.003 |
0.449 |
|
| 2018 |
Sen N, Sung P, Panda A, Arvin AM. Distinctive Roles for Type I and Type II Interferons and Interferon Regulatory Factors in the Host Cell Defense against Varicella-zoster Virus. Journal of Virology. PMID 30089701 DOI: 10.1128/JVI.01151-18 |
0.449 |
|
| 2018 |
Zerboni L, Sung P, Lee G, Arvin A. Age-associated differences in infection of human skin in the SCID mouse model of varicella-zoster virus pathogenesis. Journal of Virology. PMID 29563288 DOI: 10.1128/Jvi.00002-18 |
0.361 |
|
| 2016 |
Oliver SL, Yang E, Arvin AM. Varicella-Zoster Virus Glycoproteins: Entry, Replication, and Pathogenesis. Current Clinical Microbiology Reports. 3: 204-215. PMID 28367398 DOI: 10.1007/s40588-016-0044-4 |
0.339 |
|
| 2016 |
Yang E, Arvin AM, Oliver SL. The Glycoprotein B Cytoplasmic Domain Lysine Cluster Is Critical for Varicella Zoster Virus Cell-Cell Fusion Regulation and Infection. Journal of Virology. PMID 27795427 DOI: 10.1128/Jvi.01707-16 |
0.31 |
|
| 2016 |
Oliver SL, Yang E, Arvin AM. Dysregulated Glycoprotein B Mediated Cell-Cell Fusion Disrupts Varicella-Zoster Virus and Host Gene Transcription During Infection. Journal of Virology. PMID 27795423 DOI: 10.1128/Jvi.01613-16 |
0.394 |
|
| 2016 |
François S, Sen N, Mitton B, Xiao X, Sakamoto KM, Arvin A. Varicella-Zoster Virus Activates CREB and Inhibition of the pCREB-p300/CBP- Interaction Inhibits Viral Replication in vitro and Skin Pathogenesis in vivo. Journal of Virology. PMID 27440893 DOI: 10.1128/Jvi.00920-16 |
0.529 |
|
| 2016 |
Yang E, Arvin AM, Oliver SL. A role for the αV integrin subunit in Varicella Zoster Virus-mediated fusion and infection. Journal of Virology. PMID 27279620 DOI: 10.1128/Jvi.00792-16 |
0.39 |
|
| 2016 |
Sen N, Arvin AM. Dissecting the Molecular Mechanisms of the Tropism of Varicella-Zoster Virus for Human T Cells. Journal of Virology. 90: 3284-7. PMID 26792747 DOI: 10.1128/JVI.03375-14 |
0.395 |
|
| 2015 |
Sen N, Mukherjee G, Arvin AM. Single cell mass cytometry reveals remodeling of human T cell phenotypes by varicella zoster virus. Methods (San Diego, Calif.). 90: 85-94. PMID 26213183 DOI: 10.1016/j.ymeth.2015.07.008 |
0.395 |
|
| 2015 |
Khalil MI, Ruyechan WT, Hay J, Arvin A. Differential effects of Sp cellular transcription factors on viral promoter activation by varicella-zoster virus (VZV) IE62 protein. Virology. 485: 47-57. PMID 26207799 DOI: 10.1016/J.Virol.2015.06.031 |
0.303 |
|
| 2015 |
Zerboni L, Arvin A. Neuronal Subtype and Satellite Cell Tropism Are Determinants of Varicella-Zoster Virus Virulence in Human Dorsal Root Ganglia Xenografts In Vivo. Plos Pathogens. 11: e1004989. PMID 26090802 DOI: 10.1371/Journal.Ppat.1004989 |
0.37 |
|
| 2015 |
Buckingham EM, Carpenter JE, Jackson W, Zerboni L, Arvin AM, Grose C. Autophagic flux without a block differentiates varicella-zoster virus infection from herpes simplex virus infection. Proceedings of the National Academy of Sciences of the United States of America. 112: 256-61. PMID 25535384 DOI: 10.1073/Pnas.1417878112 |
0.414 |
|
| 2015 |
Arvin AM, Wolinsky JS, Kappos L, Morris MI, Reder AT, Tornatore C, Gershon A, Gershon M, Levin MJ, Bezuidenhoudt M, Putzki N. Varicella-zoster virus infections in patients treated with fingolimod: risk assessment and consensus recommendations for management. Jama Neurology. 72: 31-9. PMID 25419615 DOI: 10.1001/Jamaneurol.2014.3065 |
0.331 |
|
| 2014 |
Sen N, Mukherjee G, Sen A, Bendall SC, Sung P, Nolan GP, Arvin AM. Single-cell mass cytometry analysis of human tonsil T cell remodeling by varicella zoster virus. Cell Reports. 8: 633-45. PMID 25043183 DOI: 10.1016/J.Celrep.2014.06.024 |
0.387 |
|
| 2014 |
Yang E, Arvin AM, Oliver SL. The cytoplasmic domain of varicella-zoster virus glycoprotein H regulates syncytia formation and skin pathogenesis. Plos Pathogens. 10: e1004173. PMID 24874654 DOI: 10.1371/Journal.Ppat.1004173 |
0.361 |
|
| 2014 |
Zerboni L, Sen N, Oliver SL, Arvin AM. Molecular mechanisms of varicella zoster virus pathogenesis. Nature Reviews. Microbiology. 12: 197-210. PMID 24509782 DOI: 10.1038/nrmicro3215 |
0.429 |
|
| 2014 |
Khalil MI, Sommer M, Arvin A, Hay J, Ruyechan WT. Cellular transcription factor YY1 mediates the varicella-zoster virus (VZV) IE62 transcriptional activation. Virology. 449: 244-53. PMID 24418559 DOI: 10.1016/J.Virol.2013.11.029 |
0.438 |
|
| 2013 |
Khalil MI, Sommer M, Arvin A, Hay J, Ruyechan WT. Regulation of the varicella-zoster virus ORF3 promoter by cellular and viral factors. Virology. 440: 171-81. PMID 23523134 DOI: 10.1016/J.Virol.2013.02.019 |
0.358 |
|
| 2013 |
Che X, Oliver SL, Reichelt M, Sommer MH, Haas J, Roviš TL, Arvin AM. ORF11 protein interacts with the ORF9 essential tegument protein in varicella-zoster virus infection. Journal of Virology. 87: 5106-17. PMID 23427162 DOI: 10.1128/JVI.00102-13 |
0.304 |
|
| 2013 |
Wang L, Rajamani J, Sommer M, Zerboni L, Arvin AM. Identification of a hydrophobic domain in varicella-zoster virus ORF61 necessary for ORF61 self-interaction, viral replication, and skin pathogenesis. Journal of Virology. 87: 4075-9. PMID 23345513 DOI: 10.1128/JVI.02963-12 |
0.347 |
|
| 2013 |
Oliver SL, Brady JJ, Sommer MH, Reichelt M, Sung P, Blau HM, Arvin AM. An immunoreceptor tyrosine-based inhibition motif in varicella-zoster virus glycoprotein B regulates cell fusion and skin pathogenesis. Proceedings of the National Academy of Sciences of the United States of America. 110: 1911-6. PMID 23322733 DOI: 10.1073/Pnas.1216985110 |
0.371 |
|
| 2013 |
Zerboni L, Che X, Reichelt M, Qiao Y, Gu H, Arvin A. Herpes simplex virus 1 tropism for human sensory ganglion neurons in the severe combined immunodeficiency mouse model of neuropathogenesis. Journal of Virology. 87: 2791-802. PMID 23269807 DOI: 10.1128/Jvi.01375-12 |
0.436 |
|
| 2013 |
Sen N, Mukherjee G, Bendall SC, Sen A, Jager A, Sung P, Nolan GP, Johnstone I, Arvin AM. 233 Cytokine. 63: 298. DOI: 10.1016/J.Cyto.2013.06.236 |
0.367 |
|
| 2012 |
Khalil MI, Robinson M, Sommer M, Arvin A, Hay J, Ruyechan WT. An Sp1/Sp3 site in the downstream region of varicella-zoster virus (VZV) oriS influences origin-dependent DNA replication and flanking gene transcription and is important for VZV replication in vitro and in human skin. Journal of Virology. 86: 13070-80. PMID 22933283 DOI: 10.1128/Jvi.01538-12 |
0.441 |
|
| 2012 |
Sen N, Che X, Rajamani J, Zerboni L, Sung P, Ptacek J, Arvin AM. Signal transducer and activator of transcription 3 (STAT3) and survivin induction by varicella-zoster virus promote replication and skin pathogenesis. Proceedings of the National Academy of Sciences of the United States of America. 109: 600-5. PMID 22190485 DOI: 10.1073/pnas.1114232109 |
0.405 |
|
| 2012 |
Zerboni L, Sobel RA, Lai M, Triglia R, Steain M, Abendroth A, Arvin A. Apparent expression of varicella-zoster virus proteins in latency resulting from reactivity of murine and rabbit antibodies with human blood group a determinants in sensory neurons. Journal of Virology. 86: 578-83. PMID 22013055 DOI: 10.1128/Jvi.05950-11 |
0.334 |
|
| 2012 |
Reichelt M, Joubert L, Perrino J, Ko A, Phanwar I, Arvin A. 3D Reconstruction of Varicella-Zoster Virus Infected Host Cell Nuclei and PML Cages by Serial Section Array-SEM and TEM Tomography. Microscopy and Microanalysis. 18: 176-177. DOI: 10.1017/S1431927612002735 |
0.311 |
|
| 2011 |
Zerboni L, Arvin A. Investigation of varicella-zoster virus neurotropism and neurovirulence using SCID mouse-human DRG xenografts. Journal of Neurovirology. 17: 570-7. PMID 22161683 DOI: 10.1007/S13365-011-0066-X |
0.466 |
|
| 2011 |
Vleck SE, Oliver SL, Brady JJ, Blau HM, Rajamani J, Sommer MH, Arvin AM. Structure-function analysis of varicella-zoster virus glycoprotein H identifies domain-specific roles for fusion and skin tropism. Proceedings of the National Academy of Sciences of the United States of America. 108: 18412-7. PMID 22025718 DOI: 10.1073/Pnas.1111333108 |
0.351 |
|
| 2011 |
Khalil MI, Arvin A, Jones J, Ruyechan WT. A sequence within the varicella-zoster virus (VZV) OriS is a negative regulator of DNA replication and is bound by a protein complex containing the VZV ORF29 protein. Journal of Virology. 85: 12188-200. PMID 21937644 DOI: 10.1128/Jvi.05501-11 |
0.587 |
|
| 2011 |
Wang L, Oliver SL, Sommer M, Rajamani J, Reichelt M, Arvin AM. Disruption of PML nuclear bodies is mediated by ORF61 SUMO-interacting motifs and required for varicella-zoster virus pathogenesis in skin. Plos Pathogens. 7: e1002157. PMID 21901090 DOI: 10.1371/journal.ppat.1002157 |
0.45 |
|
| 2011 |
Nour AM, Reichelt M, Ku CC, Ho MY, Heineman TC, Arvin AM. Varicella-zoster virus infection triggers formation of an interleukin-1β (IL-1β)-processing inflammasome complex. The Journal of Biological Chemistry. 286: 17921-33. PMID 21385879 DOI: 10.1074/Jbc.M110.210575 |
0.367 |
|
| 2011 |
Oliver SL, Sommer MH, Reichelt M, Rajamani J, Vlaycheva-Beisheim L, Stamatis S, Cheng J, Jones C, Zehnder J, Arvin AM. Mutagenesis of varicella-zoster virus glycoprotein I (gI) identifies a cysteine residue critical for gE/gI heterodimer formation, gI structure, and virulence in skin cells. Journal of Virology. 85: 4095-110. PMID 21345964 DOI: 10.1128/JVI.02596-10 |
0.383 |
|
| 2011 |
Reichelt M, Wang L, Sommer M, Perrino J, Nour AM, Sen N, Baiker A, Zerboni L, Arvin AM. Entrapment of viral capsids in nuclear PML cages is an intrinsic antiviral host defense against varicella-zoster virus. Plos Pathogens. 7: e1001266. PMID 21304940 DOI: 10.1371/Journal.Ppat.1001266 |
0.447 |
|
| 2011 |
Che X, Oliver SL, Sommer MH, Rajamani J, Reichelt M, Arvin AM. Identification and functional characterization of the Varicella zoster virus ORF11 gene product. Virology. 412: 156-66. PMID 21276599 DOI: 10.1016/j.virol.2010.12.055 |
0.314 |
|
| 2011 |
Zerboni L, Berarducci B, Rajamani J, Jones CD, Zehnder JL, Arvin A. Varicella-zoster virus glycoprotein E is a critical determinant of virulence in the SCID mouse-human model of neuropathogenesis. Journal of Virology. 85: 98-111. PMID 20962081 DOI: 10.1128/Jvi.01902-10 |
0.501 |
|
| 2011 |
Ku CC, Che XB, Reichelt M, Rajamani J, Schaap-Nutt A, Huang KJ, Sommer MH, Chen YS, Chen YY, Arvin AM. Herpes simplex virus-1 induces expression of a novel MxA isoform that enhances viral replication. Immunology and Cell Biology. 89: 173-82. PMID 20603636 DOI: 10.1038/icb.2010.83 |
0.461 |
|
| 2011 |
Gutierrez KM, Whitley RJ, Arvin AM. Herpes Simplex Virus Infections Infectious Diseases of the Fetus and Newborn Infant. 813-833. DOI: 10.1016/B978-1-4160-6400-8.00026-2 |
0.44 |
|
| 2010 |
Abendroth A, Arvin AM, Moffat JF. Varicella-zoster virus. Preface. Current Topics in Microbiology and Immunology. 342: v-vi. PMID 20973159 |
0.42 |
|
| 2010 |
Sen N, Sommer M, Che X, White K, Ruyechan WT, Arvin AM. Varicella-zoster virus immediate-early protein 62 blocks interferon regulatory factor 3 (IRF3) phosphorylation at key serine residues: a novel mechanism of IRF3 inhibition among herpesviruses. Journal of Virology. 84: 9240-53. PMID 20631144 DOI: 10.1128/Jvi.01147-10 |
0.365 |
|
| 2010 |
Arvin AM, Moffat JF, Sommer M, Oliver S, Che X, Vleck S, Zerboni L, Ku CC. Varicella-zoster virus T cell tropism and the pathogenesis of skin infection. Current Topics in Microbiology and Immunology. 342: 189-209. PMID 20397071 DOI: 10.1007/82_2010_29 |
0.434 |
|
| 2010 |
Zerboni L, Reichelt M, Arvin A. Varicella-zoster virus neurotropism in SCID mouse-human dorsal root ganglia xenografts Current Topics in Microbiology and Immunology. 342: 255-276. PMID 20225014 DOI: 10.1007/82_2009_8 |
0.432 |
|
| 2010 |
Arvin AM, Oliver S, Reichelt M, Moffat JF, Sommer M, Zerboni L, Berarducci B. Analysis of the functions of glycoproteins E and I and their promoters during VZV replication in vitro and in skin and T-cell xenografts in the SCID mouse model of VZV pathogenesis. Current Topics in Microbiology and Immunology. 342: 129-46. PMID 20186616 DOI: 10.1007/82_2009_1 |
0.39 |
|
| 2010 |
Huch JH, Cunningham AL, Arvin AM, Nasr N, Santegoets SJ, Slobedman E, Slobedman B, Abendroth A. Impact of varicella-zoster virus on dendritic cell subsets in human skin during natural infection. Journal of Virology. 84: 4060-72. PMID 20130046 DOI: 10.1128/JVI.01450-09 |
0.301 |
|
| 2010 |
Zerboni L, Sobel RA, Ramachandran V, Rajamani J, Ruyechan W, Abendroth A, Arvin A. Expression of varicella-zoster virus immediate-early regulatory protein IE63 in neurons of latently infected human sensory ganglia. Journal of Virology. 84: 3421-30. PMID 20106930 DOI: 10.1128/Jvi.02416-09 |
0.34 |
|
| 2010 |
Berarducci B, Rajamani J, Zerboni L, Che X, Sommer M, Arvin AM. Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infection. Proceedings of the National Academy of Sciences of the United States of America. 107: 282-7. PMID 19966293 DOI: 10.1073/pnas.0912373107 |
0.368 |
|
| 2010 |
Vleck SE, Oliver SL, Reichelt M, Rajamani J, Zerboni L, Jones C, Zehnder J, Grose C, Arvin AM. Anti-glycoprotein H antibody impairs the pathogenicity of varicella-zoster virus in skin xenografts in the SCID mouse model. Journal of Virology. 84: 141-52. PMID 19828615 DOI: 10.1128/Jvi.01338-09 |
0.389 |
|
| 2009 |
Oliver SL, Sommer M, Zerboni L, Rajamani J, Grose C, Arvin AM. Mutagenesis of varicella-zoster virus glycoprotein B: putative fusion loop residues are essential for viral replication, and the furin cleavage motif contributes to pathogenesis in skin tissue in vivo. Journal of Virology. 83: 7495-506. PMID 19474103 DOI: 10.1128/Jvi.00400-09 |
0.372 |
|
| 2009 |
Wang L, Sommer M, Rajamani J, Arvin AM. Regulation of the ORF61 promoter and ORF61 functions in varicella-zoster virus replication and pathogenesis. Journal of Virology. 83: 7560-72. PMID 19457996 DOI: 10.1128/JVI.00118-09 |
0.365 |
|
| 2009 |
Reichelt M, Brady J, Arvin AM. The replication cycle of varicella-zoster virus: analysis of the kinetics of viral protein expression, genome synthesis, and virion assembly at the single-cell level. Journal of Virology. 83: 3904-18. PMID 19193797 DOI: 10.1128/JVI.02137-08 |
0.396 |
|
| 2009 |
Berarducci B, Rajamani J, Reichelt M, Sommer M, Zerboni L, Arvin AM. Deletion of the first cysteine-rich region of the varicella-zoster virus glycoprotein E ectodomain abolishes the gE and gI interaction and differentially affects cell-cell spread and viral entry. Journal of Virology. 83: 228-40. PMID 18945783 DOI: 10.1128/JVI.00913-08 |
0.396 |
|
| 2009 |
Ho DY, Arvin AM. Varicella-zoster Virus Infections Thomas' Hematopoietic Cell Transplantation: Stem Cell Transplantation, Fourth Edition. 1388-1409. DOI: 10.1002/9781444303537.ch92 |
0.431 |
|
| 2008 |
Oliver SL, Zerboni L, Sommer M, Rajamani J, Arvin AM. Development of recombinant varicella-zoster viruses expressing luciferase fusion proteins for live in vivo imaging in human skin and dorsal root ganglia xenografts. Journal of Virological Methods. 154: 182-93. PMID 18761377 DOI: 10.1016/j.jviromet.2008.07.033 |
0.341 |
|
| 2008 |
Chaudhuri V, Sommer M, Rajamani J, Zerboni L, Arvin AM. Functions of Varicella-zoster virus ORF23 capsid protein in viral replication and the pathogenesis of skin infection. Journal of Virology. 82: 10231-46. PMID 18684828 DOI: 10.1128/JVI.01890-07 |
0.363 |
|
| 2008 |
Arvin AM. Humoral and cellular immunity to varicella-zoster virus: an overview. The Journal of Infectious Diseases. 197: S58-60. PMID 18419410 DOI: 10.1086/522123 |
0.34 |
|
| 2008 |
Che X, Reichelt M, Sommer MH, Rajamani J, Zerboni L, Arvin AM. Functions of the ORF9-to-ORF12 gene cluster in varicella-zoster virus replication and in the pathogenesis of skin infection. Journal of Virology. 82: 5825-34. PMID 18400847 DOI: 10.1128/JVI.00303-08 |
0.405 |
|
| 2008 |
Reichelt M, Zerboni L, Arvin AM. Mechanisms of varicella-zoster virus neuropathogenesis in human dorsal root ganglia. Journal of Virology. 82: 3971-83. PMID 18256143 DOI: 10.1128/JVI.02592-07 |
0.394 |
|
| 2008 |
Zerbon L, Arvin AM. The pathogenesis of varicella-zoster virus neurotropism and infection Neurotropic Viral Infections. 225-250. DOI: 10.1017/CBO9780511541728.016 |
0.362 |
|
| 2007 |
Tischer BK, Kaufer BB, Sommer M, Wussow F, Arvin AM, Osterrieder N. A self-excisable infectious bacterial artificial chromosome clone of varicella-zoster virus allows analysis of the essential tegument protein encoded by ORF9. Journal of Virology. 81: 13200-8. PMID 17913822 DOI: 10.1128/Jvi.01148-07 |
0.383 |
|
| 2007 |
Zerboni L, Reichelt M, Jones CD, Zehnder JL, Ito H, Arvin AM. Aberrant infection and persistence of varicella-zoster virus in human dorsal root ganglia in vivo in the absence of glycoprotein I. Proceedings of the National Academy of Sciences of the United States of America. 104: 14086-91. PMID 17709745 DOI: 10.1073/pnas.0706023104 |
0.417 |
|
| 2007 |
Berarducci B, Sommer M, Zerboni L, Rajamani J, Arvin AM. Cellular and viral factors regulate the varicella-zoster virus gE promoter during viral replication. Journal of Virology. 81: 10258-67. PMID 17634217 DOI: 10.1128/JVI.00553-07 |
0.318 |
|
| 2007 |
Zhang Z, Rowe J, Wang W, Sommer M, Arvin A, Moffat J, Zhu H. Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system. Journal of Virology. 81: 9024-33. PMID 17581997 DOI: 10.1128/Jvi.02666-06 |
0.459 |
|
| 2007 |
Brown EL, Gardella C, Malm G, Prober CG, Forsgren M, Krantz EM, Arvin AM, Yasukawa LL, Mohan K, Brown Z, Corey L, Wald A. Effect of maternal herpes simplex virus (HSV) serostatus and HSV type on risk of neonatal herpes. Acta Obstetricia Et Gynecologica Scandinavica. 86: 523-9. PMID 17464578 DOI: 10.1080/00016340601151949 |
0.323 |
|
| 2007 |
Arvin A, Abendroth A. VZV: Immunobiology and host response Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. 700-712. DOI: 10.1017/CBO9780511545313.040 |
0.397 |
|
| 2007 |
Moffat J, Ku CC, Zerboni L, Sommer M, Arvin A. VZV: Pathogenesis and the disease consequences of primary infection Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. 675-688. DOI: 10.1017/CBO9780511545313.038 |
0.389 |
|
| 2006 |
Arvin AM. Investigations of the pathogenesis of Varicella zoster virus infection in the SCIDhu mouse model. Herpes : the Journal of the Ihmf. 13: 75-80. PMID 17147912 |
0.444 |
|
| 2006 |
Berarducci B, Ikoma M, Stamatis S, Sommer M, Grose C, Arvin AM. Essential functions of the unique N-terminal region of the varicella-zoster virus glycoprotein E ectodomain in viral replication and in the pathogenesis of skin infection. Journal of Virology. 80: 9481-96. PMID 16973553 DOI: 10.1128/Jvi.00533-06 |
0.341 |
|
| 2006 |
He XS, Holmes TH, Zhang C, Mahmood K, Kemble GW, Lewis DB, Dekker CL, Greenberg HB, Arvin AM. Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines. Journal of Virology. 80: 11756-66. PMID 16971435 DOI: 10.1128/Jvi.01460-06 |
0.335 |
|
| 2006 |
Schaap-Nutt A, Sommer M, Che X, Zerboni L, Arvin AM. ORF66 protein kinase function is required for T-cell tropism of varicella-zoster virus in vivo. Journal of Virology. 80: 11806-16. PMID 16971426 DOI: 10.1128/JVI.00466-06 |
0.36 |
|
| 2006 |
Brown EL, Morrow R, Krantz EM, Arvin AM, Prober CG, Yasukawa LL, Corey L, Wald A. Maternal herpes simplex virus antibody avidity and risk of neonatal herpes. American Journal of Obstetrics and Gynecology. 195: 115-20. PMID 16813750 DOI: 10.1016/J.Ajog.2006.02.013 |
0.345 |
|
| 2006 |
Jones JO, Arvin AM. Inhibition of the NF-kappaB pathway by varicella-zoster virus in vitro and in human epidermal cells in vivo. Journal of Virology. 80: 5113-24. PMID 16698992 DOI: 10.1128/Jvi.01956-05 |
0.6 |
|
| 2006 |
Che X, Zerboni L, Sommer MH, Arvin AM. Varicella-zoster virus open reading frame 10 is a virulence determinant in skin cells but not in T cells in vivo. Journal of Virology. 80: 3238-48. PMID 16537591 DOI: 10.1128/JVI.80.7.3238-3248.2006 |
0.455 |
|
| 2006 |
Jones JO, Sommer M, Stamatis S, Arvin AM. Mutational analysis of the varicella-zoster virus ORF62/63 intergenic region. Journal of Virology. 80: 3116-21. PMID 16501125 DOI: 10.1128/Jvi.80.6.3116-3121.2006 |
0.509 |
|
| 2006 |
Hood C, Cunningham AL, Slobedman B, Arvin AM, Sommer MH, Kinchington PR, Abendroth A. Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons. Journal of Virology. 80: 1025-31. PMID 16379003 DOI: 10.1128/Jvi.80.2.1025-1031.2006 |
0.341 |
|
| 2006 |
Ku C, Schaap A, Arvin A. Su.61. The Anti-Viral Effects of Interferon-α On Varicella-Zoster Virus (Vzv) Clinical Immunology. 119: S181. DOI: 10.1016/J.Clim.2006.04.488 |
0.647 |
|
| 2006 |
Arvin AM, Whitley RJ, Gutierrez KM. Herpes Simplex Virus Infections Infectious Diseases of the Fetus and Newborn Infant. 845-865. DOI: 10.1016/B0-72-160537-0/50028-1 |
0.44 |
|
| 2005 |
Schaap A, Fortin JF, Sommer M, Zerboni L, Stamatis S, Ku CC, Nolan GP, Arvin AM. T-cell tropism and the role of ORF66 protein in pathogenesis of varicella-zoster virus infection. Journal of Virology. 79: 12921-33. PMID 16188994 DOI: 10.1128/Jvi.79.20.12921-12933.2005 |
0.662 |
|
| 2005 |
Jones JO, Arvin AM. Viral and cellular gene transcription in fibroblasts infected with small plaque mutants of varicella-zoster virus. Antiviral Research. 68: 56-65. PMID 16118026 DOI: 10.1016/J.Antiviral.2005.06.011 |
0.609 |
|
| 2005 |
Zuranski T, Nawar H, Czechowski D, Lynch JM, Arvin A, Hay J, Ruyechan WT. Cell-type-dependent activation of the cellular EF-1alpha promoter by the varicella-zoster virus IE63 protein. Virology. 338: 35-42. PMID 15936796 DOI: 10.1016/J.Virol.2005.05.005 |
0.454 |
|
| 2005 |
Arvin A. Aging, immunity, and the varicella-zoster virus. The New England Journal of Medicine. 352: 2266-7. PMID 15930416 DOI: 10.1056/Nejmp058091 |
0.361 |
|
| 2005 |
Zerboni L, Ku CC, Jones CD, Zehnder JL, Arvin AM. Varicella-zoster virus infection of human dorsal root ganglia in vivo. Proceedings of the National Academy of Sciences of the United States of America. 102: 6490-5. PMID 15851670 DOI: 10.1073/pnas.0501045102 |
0.445 |
|
| 2005 |
Ito H, Sommer MH, Zerboni L, Baiker A, Sato B, Liang R, Hay J, Ruyechan W, Arvin AM. Role of the varicella-zoster virus gene product encoded by open reading frame 35 in viral replication in vitro and in differentiated human skin and T cells in vivo. Journal of Virology. 79: 4819-27. PMID 15795267 DOI: 10.1128/Jvi.79.8.4819-4827.2005 |
0.443 |
|
| 2005 |
Ku CC, Besser J, Abendroth A, Grose C, Arvin AM. Varicella-Zoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model. Journal of Virology. 79: 2651-8. PMID 15708984 DOI: 10.1128/Jvi.79.5.2651-2658.2005 |
0.469 |
|
| 2005 |
Zerboni L, Hinchliffe S, Sommer MH, Ito H, Besser J, Stamatis S, Cheng J, Distefano D, Kraiouchkine N, Shaw A, Arvin AM. Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model. Virology. 332: 337-46. PMID 15661165 DOI: 10.1016/j.virol.2004.10.047 |
0.379 |
|
| 2004 |
He XS, Draghi M, Mahmood K, Holmes TH, Kemble GW, Dekker CL, Arvin AM, Parham P, Greenberg HB. T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus. The Journal of Clinical Investigation. 114: 1812-9. PMID 15599406 DOI: 10.1172/Jci22797 |
0.341 |
|
| 2004 |
Besser J, Ikoma M, Fabel K, Sommer MH, Zerboni L, Grose C, Arvin AM. Differential requirement for cell fusion and virion formation in the pathogenesis of varicella-zoster virus infection in skin and T cells. Journal of Virology. 78: 13293-305. PMID 15542680 DOI: 10.1128/Jvi.78.23.13293-13305.2004 |
0.392 |
|
| 2004 |
Moffat J, Mo C, Cheng JJ, Sommer M, Zerboni L, Stamatis S, Arvin AM. Functions of the C-terminal domain of varicella-zoster virus glycoprotein E in viral replication in vitro and skin and T-cell tropism in vivo. Journal of Virology. 78: 12406-15. PMID 15507627 DOI: 10.1128/JVI.78.22.12406-12415.2004 |
0.339 |
|
| 2004 |
Ku CC, Zerboni L, Ito H, Graham BS, Wallace M, Arvin AM. Varicella-zoster virus transfer to skin by T cells and modulation of viral replication by epidermal cell interferon-α Journal of Experimental Medicine. 200: 917-925. PMID 15452178 DOI: 10.1084/jem.20040634 |
0.449 |
|
| 2004 |
Baiker A, Fabel K, Cozzio A, Zerboni L, Fabel K, Sommer M, Uchida N, He D, Weissman I, Arvin AM. Varicella-zoster virus infection of human neural cells in vivo. Proceedings of the National Academy of Sciences of the United States of America. 101: 10792-7. PMID 15247414 DOI: 10.1073/Pnas.0404016101 |
0.41 |
|
| 2004 |
Tu W, Chen S, Sharp M, Dekker C, Manganello AM, Tongson EC, Maecker HT, Holmes TH, Wang Z, Kemble G, Adler S, Arvin A, Lewis DB. Persistent and selective deficiency of CD4+ T cell immunity to cytomegalovirus in immunocompetent young children. Journal of Immunology (Baltimore, Md. : 1950). 172: 3260-7. PMID 14978134 DOI: 10.4049/Jimmunol.172.5.3260 |
0.362 |
|
| 2004 |
Baiker A, Bagowski C, Ito H, Sommer M, Zerboni L, Fabel K, Hay J, Ruyechan W, Arvin AM. The immediate-early 63 protein of Varicella-Zoster virus: analysis of functional domains required for replication in vitro and for T-cell and skin tropism in the SCIDhu model in vivo. Journal of Virology. 78: 1181-94. PMID 14722273 DOI: 10.1128/Jvi.78.3.1181-1194.2004 |
0.389 |
|
| 2003 |
Sato B, Sommer M, Ito H, Arvin AM. Requirement of Varicella-Zoster Virus Immediate-Early 4 Protein for Viral Replication Journal of Virology. 77: 12369-12372. PMID 14581575 DOI: 10.1128/JVI.77.22.12369-12372.2003 |
0.411 |
|
| 2003 |
Niizuma T, Zerboni L, Sommer MH, Ito H, Hinchliffe S, Arvin AM. Construction of varicella-zoster virus recombinants from parent Oka cosmids and demonstration that ORF65 protein is dispensable for infection of human skin and T cells in the SCID-hu mouse model. Journal of Virology. 77: 6062-5. PMID 12719598 DOI: 10.1128/JVI.77.10.6062-6065.2003 |
0.455 |
|
| 2003 |
Besser J, Sommer MH, Zerboni L, Bagowski CP, Ito H, Moffat J, Ku CC, Arvin AM. Differentiation of varicella-zoster virus ORF47 protein kinase and IE62 protein binding domains and their contributions to replication in human skin xenografts in the SCID-hu mouse. Journal of Virology. 77: 5964-74. PMID 12719588 DOI: 10.1128/JVI.77.10.5964-5974.2003 |
0.307 |
|
| 2003 |
Sato B, Ito H, Hinchliffe S, Sommer MH, Zerboni L, Arvin AM. Mutational analysis of open reading frames 62 and 71, encoding the varicella-zoster virus immediate-early transactivating protein, IE62, and effects on replication in vitro and in skin xenografts in the SCID-hu mouse in vivo. Journal of Virology. 77: 5607-20. PMID 12719553 DOI: 10.1128/JVI.77.10.5607-5620.2003 |
0.384 |
|
| 2003 |
He XS, Mahmood K, Maecker HT, Holmes TH, Kemble GW, Arvin AM, Greenberg HB. Analysis of the frequencies and of the memory T cell phenotypes of human CD8+ T cells specific for influenza A viruses. The Journal of Infectious Diseases. 187: 1075-84. PMID 12660922 DOI: 10.1086/368218 |
0.307 |
|
| 2003 |
Mo C, Lee J, Sommer MH, Arvin AM. Varicella-zoster virus infection facilitates VZV glycoprotein E trafficking to the membrane surface of melanoma cells Journal of Medical Virology. 70. PMID 12627489 DOI: 10.1002/jmv.10322 |
0.396 |
|
| 2003 |
Jones JO, Arvin AM. Microarray analysis of host cell gene transcription in response to varicella-zoster virus infection of human T cells and fibroblasts in vitro and SCIDhu skin xenografts in vivo. Journal of Virology. 77: 1268-80. PMID 12502844 DOI: 10.1128/Jvi.77.2.1268-1280.2003 |
0.6 |
|
| 2003 |
Ito H, Sommer MH, Zerboni L, He H, Boucaud D, Hay J, Ruyechan W, Arvin AM. Promoter sequences of varicella-zoster virus glycoprotein I targeted by cellular transactivating factors Sp1 and USF determine virulence in skin and T cells in SCIDhu mice in vivo. Journal of Virology. 77: 489-98. PMID 12477854 DOI: 10.1128/Jvi.77.1.489-498.2003 |
0.409 |
|
| 2002 |
Mo C, Lee J, Sommer M, Grose C, Arvin AM. The requirement of varicella zoster virus glycoprotein E (gE) for viral replication and effects of glycoprotein I on gE in melanoma cells. Virology. 304: 176-86. PMID 12504560 DOI: 10.1006/Viro.2002.1556 |
0.399 |
|
| 2002 |
Arvin AM, Sharp M, Moir M, Kinchington PR, Sadeghi-Zadeh M, Ruyechan WT, Hay J. Memory cytotoxic T cell responses to viral tegument and regulatory proteins encoded by open reading frames 4, 10, 29, and 62 of varicella-zoster virus. Viral Immunology. 15: 507-16. PMID 12479399 DOI: 10.1089/088282402760312377 |
0.353 |
|
| 2002 |
Ku CC, Padilla JA, Grose C, Butcher EC, Arvin AM. Tropism of varicella-zoster virus for human tonsillar CD4(+) T lymphocytes that express activation, memory, and skin homing markers. Journal of Virology. 76: 11425-33. PMID 12388703 DOI: 10.1128/Jvi.76.22.11425-11433.2002 |
0.37 |
|
| 2002 |
Slobedman B, Mocarski ES, Arvin AM, Mellins ED, Abendroth A. Latent cytomegalovirus down-regulates major histocompatibility complex class II expression on myeloid progenitors. Blood. 100: 2867-73. PMID 12351397 DOI: 10.1182/Blood.V100.8.2867 |
0.331 |
|
| 2002 |
Quinlivan M, Hawrami K, Barrett-Muir W, Aaby P, Arvin A, Chow VT, John TJ, Matondo P, Peiris M, Poulsen A, Siqueira M, Takahashi M, Talukder Y, Yamanishi K, Leedham-Green M, et al. The molecular epidemiology of varicella-zoster virus: evidence for geographic segregation. The Journal of Infectious Diseases. 186: 888-94. PMID 12232828 DOI: 10.1086/344228 |
0.37 |
|
| 2002 |
Moffat J, Ito H, Sommer M, Taylor S, Arvin AM. Glycoprotein I of varicella-zoster virus is required for viral replication in skin and T cells Journal of Virology. 76: 8468-8471. PMID 12134050 DOI: 10.1128/JVI.76.16.8468-8471.2002 |
0.427 |
|
| 2001 |
Arvin AM. Varicella-zoster virus: Molecular virology and virus-host interactions Current Opinion in Microbiology. 4: 442-449. PMID 11495809 DOI: 10.1016/S1369-5274(00)00233-2 |
0.433 |
|
| 2001 |
Kimberlin DW, Lin CY, Jacobs RF, Powell DA, Frenkel LM, Gruber WC, Rathore M, Bradley JS, Diaz PS, Kumar M, Arvin AM, Gutierrez K, Shelton M, Weiner LB, Sleasman JW, et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics. 108: 223-9. PMID 11483781 DOI: 10.1542/peds.108.2.223 |
0.311 |
|
| 2001 |
Sommer MH, Zagha E, Serrano OK, Ku CC, Zerboni L, Baiker A, Santos R, Spengler M, Lynch J, Grose C, Ruyechan W, Hay J, Arvin AM. Mutational analysis of the repeated open reading frames, ORFs 63 and 70 and ORFs 64 and 69, of varicella-zoster virus. Journal of Virology. 75: 8224-39. PMID 11483768 DOI: 10.1128/Jvi.75.17.8224-8239.2001 |
0.424 |
|
| 2001 |
Hata A, Zerboni L, Sommer M, Kaspar AA, Clayberger C, Krensky AM, Arvin AM. Granulysin blocks replication of varicella-zoster virus and triggers apoptosis of infected cells. Viral Immunology. 14: 125-33. PMID 11398808 DOI: 10.1089/088282401750234501 |
0.417 |
|
| 2001 |
Abendroth A, Arvin A. Immune evasion mechanisms of Varicella-Zoster Virus Archives of Virology, Supplement. 99-107. PMID 11339556 DOI: 10.1007/978-3-7091-6259-0_11 |
0.416 |
|
| 2001 |
Abendroth A, Lin I, Slobedman B, Ploegh H, Arvin AM. Varicella-zoster virus retains major histocompatibility complex class I proteins in the golgi compartment of infected cells Journal of Virology. 75: 4878-4888. PMID 11312359 DOI: 10.1128/Jvi.75.10.4878-4888.2001 |
0.373 |
|
| 2001 |
Abendroth A, Arvin AM. Immune evasion as a pathogenic mechanism of varicella zoster virus Seminars in Immunology. 13: 27-39. PMID 11289797 DOI: 10.1006/smim.2001.0293 |
0.409 |
|
| 2001 |
Wang ZH, Gershon MD, Lungu O, Zhu Z, Mallory S, Arvin AM, Gershon AA. Essential role played by the C-terminal domain of glycoprotein I in envelopment of varicella-zoster virus in the trans-Golgi network: interactions of glycoproteins with tegument. Journal of Virology. 75: 323-40. PMID 11119602 DOI: 10.1128/Jvi.75.1.323-340.2001 |
0.307 |
|
| 2000 |
Santos RA, Hatfield CC, Cole NL, Padilla JA, Moffat JF, Arvin AM, Ruyechan WT, Hay J, Grose C. Varicella-zoster virus gE escape mutant VZV-MSP exhibits an accelerated cell-to-cell spread phenotype in both infected cell cultures and SCID-hu mice. Virology. 275: 306-17. PMID 10998331 DOI: 10.1006/Viro.2000.0507 |
0.39 |
|
| 2000 |
Zerboni L, Sommer M, Ware CF, Arvin AM. Varicella-zoster virus infection of a human CD4-positive T-cell line Virology. 270: 278-285. PMID 10792986 DOI: 10.1006/viro.2000.0304 |
0.485 |
|
| 2000 |
Asanuma H, Sharp M, Maecker HT, Maino VC, Arvin AM. Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression Journal of Infectious Diseases. 181: 859-866. PMID 10720505 DOI: 10.1086/315347 |
0.333 |
|
| 2000 |
Cha TA, Kao K, Zhao J, Fast PE, Mendelman PM, Arvin A. Genotypic stability of cold-adapted influenza virus vaccine in an efficacy clinical trial Journal of Clinical Microbiology. 38: 839-845. PMID 10655394 DOI: 10.1128/Jcm.38.2.839-845.2000 |
0.383 |
|
| 2000 |
Abendroth A, Slobedman B, Lee E, Mellins E, Wallace M, Arvin AM. Modulation of major histocompatibility class II protein expression by varicella-zoster virus. Journal of Virology. 74: 1900-7. PMID 10644363 DOI: 10.1128/JVI.74.4.1900-1907.2000 |
0.304 |
|
| 1999 |
Abendroth A, Arvin AM. Varicella-zoster virus immune evasion Immunological Reviews. 168: 143-156. PMID 10399071 DOI: 10.1111/J.1600-065X.1999.Tb01289.X |
0.518 |
|
| 1999 |
Mo C, Suen J, Sommer M, Arvin A. Characterization of varicella-zoster virus glycoprotein K (open reading frame 5) and its role in virus growth Journal of Virology. 73: 4197-4207. PMID 10196316 DOI: 10.1128/Jvi.73.5.4197-4207.1999 |
0.563 |
|
| 1998 |
Sadzot-Delvaux C, Arvin AM, Rentier B. Varicella-zoster virus IE63, a virion component expressed during latency and acute infection, elicits humoral and cellular immunity Journal of Infectious Diseases. 178. PMID 9852972 |
0.384 |
|
| 1998 |
Mallory S, Sommer M, Arvin AM. Analysis of the glycoproteins I and E of varicella-zoster virus (VZV) using deletional mutations of VZV cosmids. The Journal of Infectious Diseases. 178: S22-6. PMID 9852968 |
0.412 |
|
| 1998 |
Moffat JF, Zerboni L, Sommer MH, Heineman TC, Cohen JI, Kaneshima H, Arvin AM. The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse. Proceedings of the National Academy of Sciences of the United States of America. 95: 11969-74. PMID 9751774 DOI: 10.1073/Pnas.95.20.11969 |
0.439 |
|
| 1998 |
Moffat JF, Zerboni L, Kinchington PR, Grose C, Kaneshima H, Arvin AM. Attenuation of the Vaccine Oka Strain of Varicella-Zoster Virus and Role of Glycoprotein C in Alphaherpesvirus Virulence Demonstrated in the SCID-hu Mouse Journal of Virology. 72: 965-974. DOI: 10.1128/Jvi.72.2.965-974.1998 |
0.368 |
|
| 1997 |
Mallory S, Sommer M, Arvin AM. Mutational analysis of the role of glycoprotein I in varicella-zoster virus replication and its effects on glycoprotein E conformation and trafficking. Journal of Virology. 71: 8279-88. PMID 9343180 |
0.412 |
|
| 1997 |
Arvin AM, Prober CG. Herpes simplex virus type 2 - A persistent problem New England Journal of Medicine. 337: 1158-1159. PMID 9329938 DOI: 10.1056/NEJM199710163371609 |
0.32 |
|
| 1997 |
Lowry PW, Koropchak CM, Choi CYH, Mocarski ES, Kern ER, Kinchington PR, Arvin AM. The synthesis and immunogenicity of varicella-zoster virus glycoprotein E and immediate-early protein (IE62) expressed in recombinant herpes simplex virus-1 Antiviral Research. 33: 187-200. PMID 9037375 DOI: 10.1016/S0166-3542(96)01014-5 |
0.403 |
|
| 1997 |
Moffat J, Zerboni L, Kinchington P, Grose C, Kaneshima H, Arvin A. Virologic basis for the attenuation of the vaccine Oka strain of varicella-zoster virus Clinical Infectious Diseases. 25: 465. |
0.381 |
|
| 1996 |
Kimberlin D, Powell D, Gruber W, Diaz P, Arvin A, Kumar M, Jacobs R, Van Dyke R, Burchett S, Soong SJ, Lakeman A, Whitley R. Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial. The Pediatric Infectious Disease Journal. 15: 247-54. PMID 8852914 DOI: 10.1097/00006454-199603000-00014 |
0.383 |
|
| 1996 |
Arvin AM. Varicella-zoster virus: Overview and clinical manifestations Seminars in Dermatology. 15: 4-7. PMID 8840410 |
0.37 |
|
| 1996 |
Arvin AM, Moffat JF, Redman R. Varicella-zoster virus: Aspects of pathogenesis and host respone to natural infection and varicella vaccine Advances in Virus Research. 46: 263-309. PMID 8824702 |
0.35 |
|
| 1996 |
Arvin AM. Varicella-zoster virus. Clinical Microbiology Reviews. 9: 361-381. DOI: 10.1128/CMR.9.3.361 |
0.439 |
|
| 1995 |
Arvin AM. Aspects of the host response to varicella-zoster virus: A review of recent observations Neurology. 45. PMID 8545016 DOI: 10.1212/WNL.45.12_Suppl_8.S36 |
0.304 |
|
| 1995 |
Watson B, Rothstein E, Bernstein H, Arbeter A, Arvin A, Chartrand S, Clements D, Kumar ML, Reisinger K, Blatter M, Starr SE, Staehle B, Ngai A, White CJ. Safety and Cellular and Humoral Immune Responses of a Booster Dose of Varicella Vaccine 6 Years after Primary Immunization The Journal of Infectious Diseases. 172: 217-219. PMID 7797914 DOI: 10.1093/Infdis/172.1.217 |
0.323 |
|
| 1993 |
Boucher FD, Yasukawa LL, Kerns K, Kastelein M, Arvin AM, Prober CG. Detection of antibodies to herpes simplex virus type 2 with a mammalian cell line expressing glycoprotein gG-2. Clinical and Diagnostic Virology. 1: 29-38. PMID 15566716 DOI: 10.1016/0928-0197(93)90031-Y |
0.368 |
|
| 1993 |
Carmack MA, Twiss J, Enzmann DR, Amylon MD, Arvin AM. Multifocal leukoencephalitis caused by varicella-zoster virus in a child with leukemia: successful treatment with acyclovir. The Pediatric Infectious Disease Journal. 12: 402-6. PMID 8392165 DOI: 10.1097/00006454-199305000-00011 |
0.317 |
|
| 1993 |
Lowry PW, Sabella C, Koropchak CM, Watson BN, Thackray HM, Abbruzzi GM, Arvin AM. Investigation of the pathogenesis of varicella-zoster virus infection in guinea pigs by using polymerase chain reaction. The Journal of Infectious Diseases. 167: 78-83. PMID 8380293 DOI: 10.1093/infdis/167.1.78 |
0.328 |
|
| 1993 |
Sabella C, Lowry PW, Abbruzzi GM, Koropchak CM, Kinchington PR, Sadegh-Zadeh M, Hay J, Ruyechan WT, Arvin AM. Immunization with the immediate-early tegument protein (open reading frame 62) of varicella-zoster virus protects guinea pigs against virus challenge Journal of Virology. 67: 7673-7676. PMID 8230489 DOI: 10.1128/Jvi.67.12.7673-7676.1993 |
0.337 |
|
| 1993 |
Arvin AM, Prober CG. Analysis of the epidemiology and pathogenesis of herpes simplex virus (HSV) infections in pregnant women and infants using the HSV-2 glycoprotein G antibody assay Infectious Agents and Disease. 2: 375-382. PMID 8012738 |
0.322 |
|
| 1993 |
Arvin AM. Progress in the treatment and prevention of varicella Current Opinion in Infectious Diseases. 6: 553-557. |
0.333 |
|
| 1992 |
Arvin AM, Prober CG. Herpes simplex virus infections: the genital tract and the newborn Pediatrics in Review. 13: 107-112. PMID 1565589 |
0.43 |
|
| 1992 |
Lowry PW, Solem S, Watson BN, Koropchak CM, Thackray HM, Kinchington PR, Ruyechan WT, Ling P, Hay J, Arvin AM. Immunity in strain 2 guinea-pigs inoculated with vaccinia virus recombinants expressing varicella-zoster virus glycoproteins I, IV, V or the protein product of the immediate early gene 62 Journal of General Virology. 73: 811-819. PMID 1321876 DOI: 10.1099/0022-1317-73-4-811 |
0.381 |
|
| 1992 |
Arvin AM. Cell-Mediated Immunity to Varicella-Zoster Virus Journal of Infectious Diseases. 166: S35-S41. PMID 1320649 DOI: 10.1093/infdis/166.Supplement_1.S35 |
0.33 |
|
| 1992 |
Safrin S, Arvin A, Mills J, Ashley R. Comparison of the western immunoblot assay and a glycoprotein G enzyme immunoassay for detection of serum antibodies to herpes simplex virus type 2 in patients with AIDS Journal of Clinical Microbiology. 30: 1312-1314. PMID 1316370 DOI: 10.1128/Jcm.30.5.1312-1314.1992 |
0.409 |
|
| 1992 |
Kulhanjian JA, Soroush V, Au DS, Bronzan RN, Yasukawa LL, Weylman LE, Arvin AM, Prober CG. Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy. The New England Journal of Medicine. 326: 916-20. PMID 1311799 DOI: 10.1056/NEJM199204023261403 |
0.302 |
|
| 1992 |
Wilson A, Sharp M, Koropchak CM, Ting SF, Arvin AM. Subclinical varicella-zoster virus viremia, herpes zoster, and t lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation Journal of Infectious Diseases. 165: 119-126. PMID 1309369 DOI: 10.1093/infdis/165.1.119 |
0.31 |
|
| 1992 |
Kinchington PR, Hougland JK, Arvin AM, Ruyechan WT, Hay J. The varicella-zoster virus immediate-early protein IE62 is a major component of virus particles Journal of Virology. 66: 359-366. PMID 1309252 DOI: 10.1128/Jvi.66.1.359-366.1992 |
0.388 |
|
| 1992 |
Whitley R, Arvin A, Prober C, Corey L, Burchett S, Plotkin S, Starr S, Jacobs R, Powell D, Nahmias A, Sumaya C, Edwards K, Alford C, Caddell G, Soong S, et al. Predictors of morbidity and mortality in neonates with herpes simplex virus infections International Journal of Gynecology & Obstetrics. 37: 68-69. DOI: 10.1016/0020-7292(92)90998-X |
0.329 |
|
| 1992 |
Whitley R, Arvin A, Prober C, Burchett S, Corey L, Powell D, Plotkin S, Starr S, Alford C, Connor J, Jacobs R, Nahmias A, Soong S, Laughlin C, Benton J, et al. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection International Journal of Gynecology & Obstetrics. 37: 68-68. DOI: 10.1016/0020-7292(92)90997-W |
0.472 |
|
| 1992 |
KULHANJIAN JA, SOROUSH V, AU DS, BRONZA RN, YASUKAWA LL, WEYLMAN LE, ARVIN AM, PROBER CG. Identification of Women at Unsuspected Risk of Primary Infection With Herpes Simplex Virus Type 2 During Pregnancy Obstetrical & Gynecological Survey. 47: 610-611. DOI: 10.1016/0020-7292(92)90671-5 |
0.396 |
|
| 1991 |
Whitley R, Arvin A, Prober C, Corey L, Burchett S, Plotkin S, Starr S, Jacobs R, Powell D, Nahmias A, Sumaya G, Edwards K, Alford C, Caddell G, Soong SJ, et al. Predictors of morbidity and mortality in neonates with herpes simplex virus infections New England Journal of Medicine. 324: 450-454. PMID 1988830 DOI: 10.1016/0020-7292(92)90998-X |
0.405 |
|
| 1991 |
Whitley R, Arvin A, Prober C, Burchett S, Corey L, Powell D, Plotkin S, Starr S, Alford C, Connor J. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group. The New England Journal of Medicine. 324: 444-9. PMID 1988829 DOI: 10.1056/NEJM199102143240703 |
0.357 |
|
| 1991 |
Arvin AM. Relationships between maternal immunity to herpes simplex virus and the risk of neonatal herpesvirus infection Reviews of Infectious Diseases. 13: S953-S955. PMID 1664133 DOI: 10.1093/clind/13.Supplement_11.S953 |
0.364 |
|
| 1991 |
WHITLEY R, ARVIN A, PROBER C, COREY L, BURCHETT S, PLOTKIN S, STARR S, JACOBS R, POWELL D, NAHMIAS A, SUMAYA C, EDWARDS K, ALFORD C, CADDELL G, SOONG S. Predictors of Morbidity and Mortality in Neonates with Herpes Simplex Virus Infections Obstetrical & Gynecological Survey. 46: 451-452. DOI: 10.1097/00006254-199107000-00013 |
0.329 |
|
| 1990 |
Arvin AM, Koropchak CM, Sharp M, Bergen R, Diaz PS. The T-lymphocyte response to varicella-zoster viral proteins Advances in Experimental Medicine and Biology. 278: 71-81. PMID 1963047 |
0.304 |
|
| 1990 |
Arvin AM. Herpes simplex virus infections Pediatric Infectious Disease Journal. 9: 764. |
0.44 |
|
| 1989 |
Koropchak CM, Solem SM, Diaz PS, Arvin AM. Investigation of varicella-zoster virus infection of lymphocytes by in situ hybridization Journal of Virology. 63: 2392-2395. PMID 2539528 |
0.409 |
|
| 1989 |
Diaz PS, Smith S, Hunter E, Arvin AM. T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine Journal of Immunology. 142: 636-641. PMID 2536059 |
0.327 |
|
| 1988 |
Prober CG, Hensleigh PA, Boucher FD, Yasukawa LL, Au DS, Arvin AM. Use of routine viral cultures at delivery to identify neonates exposed to herpes simplex virus. The New England Journal of Medicine. 318: 887-91. PMID 2832756 DOI: 10.1056/NEJM198804073181404 |
0.312 |
|
| 1987 |
Hutto C, Arvin A, Jacobs R, Steele R, Stagno S, Lyrene R, Willett L, Powell D, Andersen R, Werthammer J. Intrauterine herpes simplex virus infections. The Journal of Pediatrics. 110: 97-101. PMID 3794894 DOI: 10.1016/S0022-3476(87)80298-6 |
0.404 |
|
| 1987 |
Prober CG, Arvin AM. Perinatal viral infections European Journal of Clinical Microbiology. 6: 245-261. PMID 3040392 DOI: 10.1007/BF02017608 |
0.429 |
|
| 1987 |
Prober CG, Sullender WM, Yasukawa LL, Au DS, Yeager AS, Arvin AM. Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections. The New England Journal of Medicine. 316: 240-4. PMID 3025727 DOI: 10.1056/NEJM198701293160503 |
0.365 |
|
| 1987 |
Sullender WM, Miller JL, Yasukawa LL, Bradley JS, Black SB, Yeager AS, Arvin AM. Humoral and cell-mediated immunity in neonates with herpes simplex virus infection. The Journal of Infectious Diseases. 155: 28-37. PMID 3025306 DOI: 10.1093/infdis/155.1.28 |
0.31 |
|
| 1987 |
Arvin AM, Solem SM, Koropchak CM, Kinney-Thomas E, Paryani SG. Humoral and cellular immunity to varicella-zoster virus glycoprotein gpI and to a non-glycosylated protein, p170, in the strain 2 guinea-pig. The Journal of General Virology. 2449-54. PMID 2821181 DOI: 10.1099/0022-1317-68-9-2449 |
0.314 |
|
| 1987 |
Prober CG, Sullender WM, Yasukawa LL, Au DS, Yeager AS, Arvin AM. Low Risk of Herpes Simplex Virus Infections in Neonates Exposed to the Virus at the Time of Vaginal Delivery to Mothers with Recurrent Genital Herpes Simplex Virus Infections Obstetric Anesthesia Digest. 7: 48. DOI: 10.1097/00132582-198707000-00009 |
0.424 |
|
| 1987 |
Paryani SG, Arvin AM. Intrauterine infection with varicella-zoster virus after maternal varicella Obstetrical and Gynecological Survey. 42: 106-107. |
0.4 |
|
| 1986 |
Arvin AM, Koropchak CM, Williams BR, Grumet FC, Foung SK. Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection. The Journal of Infectious Diseases. 154: 422-9. PMID 3016110 DOI: 10.1093/infdis/154.3.422 |
0.305 |
|
| 1985 |
Foung SK, Perkins S, Koropchak C, Fishwild DM, Wittek AE, Engleman EG, Grumet FC, Arvin AM. Human monoclonal antibodies neutralizing varicella-zoster virus. The Journal of Infectious Diseases. 152: 280-5. PMID 2993433 DOI: 10.1093/infdis/152.2.280 |
0.401 |
|
| 1984 |
Palumbo PE, Arvin AM, Koropchak CM, Wittek AE. Investigation of varicella-zoster virus-infected cell proteins that elicit antibody production during primary varicella using the immune transfer method Journal of General Virology. 65: 2141-2147. PMID 6096492 |
0.3 |
|
| 1983 |
Schmidt NJ, Arvin AM, Martin DP, Gard EA. Serological investigation of an outbreak of simian varicella in Erythrocebus patas monkeys Journal of Clinical Microbiology. 18: 901-904. PMID 6313751 |
0.378 |
|
| 1982 |
Rasmussen L, Arvin A. Chemotherapy-induced immunosuppression Environmental Health Perspectives. 43: 21-25. PMID 7037385 DOI: 10.1289/Ehp.824321 |
0.307 |
|
| 1982 |
Pollard RB, Arvin AM, Gamberg P, Rand KH, Gallagher JG, Merigan TC. Specific cell-mediated immunity and infections with herpes viruses in cardiac transplant recipients. The American Journal of Medicine. 73: 679-87. PMID 6291387 DOI: 10.1016/0002-9343(82)90410-7 |
0.326 |
|
| 1981 |
YEAGER AS, ARVIN AM, URBANI LJ, KEMP JA. Relationship of Antibody to Outcome in Neonatal Herpes Simplex Virus Infections Obstetrical & Gynecological Survey. 36: 191-192. DOI: 10.1097/00006254-198104000-00012 |
0.346 |
|
| 1981 |
Yeager AS, Arvin AM, Urbani LJ, Kemp JA. Relationship of antibody to outcome in neonatal herpes simplex virus infections Obstetrical and Gynecological Survey. 36: 191-192. |
0.346 |
|
| 1980 |
Arvin AM, Pollard RB, Rasmussen LE, Merigan TC. Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma. The Journal of Clinical Investigation. 65: 869-78. PMID 6244336 DOI: 10.1172/Jci109739 |
0.354 |
|
| 1978 |
Arvin AM, Pollard RB, Rasmussen LE, Rand KH, Merigan TC. Lymphocyte transformation and interferon production as measures of cellular immunity in lymphoma patients. Iarc Scientific Publications. 745-51. PMID 221398 |
0.315 |
|
| 1977 |
Rand KH, Rasmussen LE, Pollard RB, Arvin A, Merigan TC. Cellular immunity and herpesvirus infections in cardiac transplant patients New England Journal of Medicine. 296: 1372-1377. PMID 193008 DOI: 10.1056/Nejm197706162962402 |
0.498 |
|
| Show low-probability matches. |